Loading...

HX H

H

HAOXI HEALTH TECHNOLOGY LTD

(HAO)

2026 6-K

Extraordinary Meeting Notice

21 May '26

Share Issuance Agreement

19 May '26

Securities Offering

12 May '26

Financial Statements Report

22 Apr '26

Auditor Change

6 Apr '26

Director Changes

6 Mar '26

Termination of Agreement

10 Feb '26

New Sales Agreement

23 Jan '26

Shareholder Meeting Results

10 Dec '25

Securities Offering Update

3 Dec '25

Extraordinary Meeting Notice

12 Nov '25

Private Placement Closed

24 Oct '25

Securities Offering

17 Oct '25

Financial Report Filing

23 Apr '25

Management Change

14 Apr '25

Annual Meeting Results

14 Jan '25

Annual Meeting Notice

19 Dec '24

Warrant Exchange Agreement

27 Nov '24

Nasdaq Notification

6 Nov '24

CFO Change

25 Sep '24

Offering Closure Update

23 Sep '24

Financial Results Report

31 May '24

Rebate Agreement

7 May '24

Advertising Partnership

3 May '24

IPO Over-Allotment

8 Mar '24

IPO Closing Summary

30 Jan '24

External Links:

SEC

On May 18, 2026, Haoxi Health Technology Ltd agreed to sell 40,000,000 Class B shares to CEO Zhen Fan at $0.018 per share for a total of $720,000, intended for working capital. Following the sale, Zhen Fan will control about 83.83% of the company's voting power.

AI Assistant

HAOXI HEALTH TECHNOLOGY LTD

2026

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.